Overview
Stem Q2 2025 revenue rises 13% YoY to $38.4 mln, beating estimates
Co achieves positive adjusted EBITDA of $3.8 mln, up from $(11.3) mln
Net income at $202.5 mln vs. $582.3 mln loss in Q2 2024
Outlook
Stem reaffirms 2025 revenue guidance of $125 mln to $175 mln
Company expects 2025 non-GAAP gross margin of 30% to 40%
Stem anticipates 2025 adjusted EBITDA between $(10) mln and $5 mln
Company projects year-end ARR of $55 mln to $65 mln
Result Drivers
COST SAVINGS - Achieved positive adjusted EBITDA through cost savings efforts
DEBT REFINANCING - One-time gain on extinguishment of debt contributed to positive net income
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$38.40 mln
$32.60 mln (3 Analysts)
Q2 Net Income
$202.50 mln
Q2 Adjusted EBITDA
$3.80 mln
Q2 Gross Margin
33.0%
Q2 Adjusted Gross Margin
49.0%
Q2 Order Backlog
$26.80 mln
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the renewable energy equipment & services peer group is "buy."
Wall Street's median 12-month price target for Stem Inc is $7.50, about 55.3% below its August 6 closing price of $11.65
Press Release: ID:nBw3ZTTVPa
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)